Effect of atorvastatin on intracellular calcium uptake in coronary smooth muscle cells from diabetic pigs fed an atherogenic diet

Brent J F Hill, Joseph L. Dixon, Michael Sturek

Research output: Contribution to journalArticle

37 Citations (Scopus)

Abstract

Intracellular Ca2+ store loading has been shown to alter proliferation and apoptosis of several cell types. In addition, HMG-CoA reductase inhibitors (i.e. atorvastatin) are effective in treating diabetic dyslipidemic patients. Thus, we hypothesized that chronic atorvastatin treatment would prevent increased Ca2+ uptake into intracellular Ca2+ stores in vascular smooth muscle cells from diabetic dyslipidemic pigs. Male Yucatan pigs were divided into four groups for 20 weeks - (1) low fat fed (control); (2) hyperlipidemic (F); (3) alloxan-induced diabetic dyslipidemic (DF); and (4) diabetic dyslipidemic pigs treated with atorvastatin (DFA). The F, DF, and DFA groups were fed a high fat/cholesterol diet. Cells were isolated from the coronary artery and the myoplasmic Ca2+ (Cam) response measured using single cell fura-2 imaging. The Cam response to caffeine (5 mM to release Ca2+ from the sarcoplasmic reticulum, SR) and ionomycin (10 μM; to release the total Ca2+ store) was determined in either the presence of low Na (19Na; inhibits Na+-Ca2+ exchange), thapsigargin (TSG; inhibits the SR Ca2+ pump), and a 19Na + TSG solution. Low Na induced the uptake of Ca2+ into both SR and non-SR Ca2+ stores in the DF group, but not the DFA group. Furthermore, after depletion of the SR Ca2+ store with TSG, 19Na evoked Ca2+ uptake into non-SR Ca2+ stores in all three groups except in the DFA group. In summary, this study demonstrates that atorvastatin prevents the enhanced uptake of Ca2+ by SR and non-SR Ca2+ stores in diabetic dyslipidemic pigs.

Original languageEnglish (US)
Pages (from-to)117-124
Number of pages8
JournalAtherosclerosis
Volume159
Issue number1
DOIs
StatePublished - 2001
Externally publishedYes

Fingerprint

Atherogenic Diet
Smooth Muscle Myocytes
Swine
Calcium
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Alloxan
Ionomycin
Thapsigargin
Fura-2
Sarcoplasmic Reticulum
High Fat Diet
Caffeine
Vascular Smooth Muscle
Coronary Vessels
Fats
Cholesterol
Apoptosis
Atorvastatin Calcium

Keywords

  • Calcium
  • Dyslipidemia
  • HMG-CoA reductase
  • Ionomycin
  • Sarcoplasmic reticulum

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Effect of atorvastatin on intracellular calcium uptake in coronary smooth muscle cells from diabetic pigs fed an atherogenic diet. / Hill, Brent J F; Dixon, Joseph L.; Sturek, Michael.

In: Atherosclerosis, Vol. 159, No. 1, 2001, p. 117-124.

Research output: Contribution to journalArticle

@article{19e65db939ab4beab9bb4406ac43363a,
title = "Effect of atorvastatin on intracellular calcium uptake in coronary smooth muscle cells from diabetic pigs fed an atherogenic diet",
abstract = "Intracellular Ca2+ store loading has been shown to alter proliferation and apoptosis of several cell types. In addition, HMG-CoA reductase inhibitors (i.e. atorvastatin) are effective in treating diabetic dyslipidemic patients. Thus, we hypothesized that chronic atorvastatin treatment would prevent increased Ca2+ uptake into intracellular Ca2+ stores in vascular smooth muscle cells from diabetic dyslipidemic pigs. Male Yucatan pigs were divided into four groups for 20 weeks - (1) low fat fed (control); (2) hyperlipidemic (F); (3) alloxan-induced diabetic dyslipidemic (DF); and (4) diabetic dyslipidemic pigs treated with atorvastatin (DFA). The F, DF, and DFA groups were fed a high fat/cholesterol diet. Cells were isolated from the coronary artery and the myoplasmic Ca2+ (Cam) response measured using single cell fura-2 imaging. The Cam response to caffeine (5 mM to release Ca2+ from the sarcoplasmic reticulum, SR) and ionomycin (10 μM; to release the total Ca2+ store) was determined in either the presence of low Na (19Na; inhibits Na+-Ca2+ exchange), thapsigargin (TSG; inhibits the SR Ca2+ pump), and a 19Na + TSG solution. Low Na induced the uptake of Ca2+ into both SR and non-SR Ca2+ stores in the DF group, but not the DFA group. Furthermore, after depletion of the SR Ca2+ store with TSG, 19Na evoked Ca2+ uptake into non-SR Ca2+ stores in all three groups except in the DFA group. In summary, this study demonstrates that atorvastatin prevents the enhanced uptake of Ca2+ by SR and non-SR Ca2+ stores in diabetic dyslipidemic pigs.",
keywords = "Calcium, Dyslipidemia, HMG-CoA reductase, Ionomycin, Sarcoplasmic reticulum",
author = "Hill, {Brent J F} and Dixon, {Joseph L.} and Michael Sturek",
year = "2001",
doi = "10.1016/S0021-9150(01)00501-9",
language = "English (US)",
volume = "159",
pages = "117--124",
journal = "Atherosclerosis",
issn = "0021-9150",
publisher = "Elsevier Ireland Ltd",
number = "1",

}

TY - JOUR

T1 - Effect of atorvastatin on intracellular calcium uptake in coronary smooth muscle cells from diabetic pigs fed an atherogenic diet

AU - Hill, Brent J F

AU - Dixon, Joseph L.

AU - Sturek, Michael

PY - 2001

Y1 - 2001

N2 - Intracellular Ca2+ store loading has been shown to alter proliferation and apoptosis of several cell types. In addition, HMG-CoA reductase inhibitors (i.e. atorvastatin) are effective in treating diabetic dyslipidemic patients. Thus, we hypothesized that chronic atorvastatin treatment would prevent increased Ca2+ uptake into intracellular Ca2+ stores in vascular smooth muscle cells from diabetic dyslipidemic pigs. Male Yucatan pigs were divided into four groups for 20 weeks - (1) low fat fed (control); (2) hyperlipidemic (F); (3) alloxan-induced diabetic dyslipidemic (DF); and (4) diabetic dyslipidemic pigs treated with atorvastatin (DFA). The F, DF, and DFA groups were fed a high fat/cholesterol diet. Cells were isolated from the coronary artery and the myoplasmic Ca2+ (Cam) response measured using single cell fura-2 imaging. The Cam response to caffeine (5 mM to release Ca2+ from the sarcoplasmic reticulum, SR) and ionomycin (10 μM; to release the total Ca2+ store) was determined in either the presence of low Na (19Na; inhibits Na+-Ca2+ exchange), thapsigargin (TSG; inhibits the SR Ca2+ pump), and a 19Na + TSG solution. Low Na induced the uptake of Ca2+ into both SR and non-SR Ca2+ stores in the DF group, but not the DFA group. Furthermore, after depletion of the SR Ca2+ store with TSG, 19Na evoked Ca2+ uptake into non-SR Ca2+ stores in all three groups except in the DFA group. In summary, this study demonstrates that atorvastatin prevents the enhanced uptake of Ca2+ by SR and non-SR Ca2+ stores in diabetic dyslipidemic pigs.

AB - Intracellular Ca2+ store loading has been shown to alter proliferation and apoptosis of several cell types. In addition, HMG-CoA reductase inhibitors (i.e. atorvastatin) are effective in treating diabetic dyslipidemic patients. Thus, we hypothesized that chronic atorvastatin treatment would prevent increased Ca2+ uptake into intracellular Ca2+ stores in vascular smooth muscle cells from diabetic dyslipidemic pigs. Male Yucatan pigs were divided into four groups for 20 weeks - (1) low fat fed (control); (2) hyperlipidemic (F); (3) alloxan-induced diabetic dyslipidemic (DF); and (4) diabetic dyslipidemic pigs treated with atorvastatin (DFA). The F, DF, and DFA groups were fed a high fat/cholesterol diet. Cells were isolated from the coronary artery and the myoplasmic Ca2+ (Cam) response measured using single cell fura-2 imaging. The Cam response to caffeine (5 mM to release Ca2+ from the sarcoplasmic reticulum, SR) and ionomycin (10 μM; to release the total Ca2+ store) was determined in either the presence of low Na (19Na; inhibits Na+-Ca2+ exchange), thapsigargin (TSG; inhibits the SR Ca2+ pump), and a 19Na + TSG solution. Low Na induced the uptake of Ca2+ into both SR and non-SR Ca2+ stores in the DF group, but not the DFA group. Furthermore, after depletion of the SR Ca2+ store with TSG, 19Na evoked Ca2+ uptake into non-SR Ca2+ stores in all three groups except in the DFA group. In summary, this study demonstrates that atorvastatin prevents the enhanced uptake of Ca2+ by SR and non-SR Ca2+ stores in diabetic dyslipidemic pigs.

KW - Calcium

KW - Dyslipidemia

KW - HMG-CoA reductase

KW - Ionomycin

KW - Sarcoplasmic reticulum

UR - http://www.scopus.com/inward/record.url?scp=0034748490&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034748490&partnerID=8YFLogxK

U2 - 10.1016/S0021-9150(01)00501-9

DO - 10.1016/S0021-9150(01)00501-9

M3 - Article

C2 - 11689213

AN - SCOPUS:0034748490

VL - 159

SP - 117

EP - 124

JO - Atherosclerosis

JF - Atherosclerosis

SN - 0021-9150

IS - 1

ER -